Mass tort settlement news this week features several landmark developments across pharmaceutical, environmental, and consumer product litigation. The week of May 11, 2026, brought new DOJ settlements totaling hundreds of millions of dollars. Meanwhile, ongoing MDL cases continued to advance toward critical bellwether trials. Readers tracking active MDL cases will find significant movement across multiple categories.
Pharmaceutical Mass Tort Settlement News This Week
The biggest pharmaceutical mass tort settlement news came from the Department of Justice. On May 12, Gilead Sciences agreed to pay $202 million to resolve kickback allegations. The government claimed Gilead used speaker programs to pay doctors to prescribe its HIV drugs. In addition, Takeda agreed to pay $13.6 million on May 14 for improper physician payments. Assertio Therapeutics also settled for $3.6 million over marketing its fentanyl product Lazanda.
Opioid litigation continues to produce significant results. South Carolina’s Opioid Recovery Fund received $250 million in settlement funds this week. The Purdue Pharma $7.4 billion global settlement became legally effective on May 1, 2026. As a result, states across the country are now distributing funds to communities devastated by the opioid crisis. Texas alone secured $286.5 million from Purdue and the Sackler family. Anyone affected by the opioid crisis should consult a licensed attorney about potential recovery options.
Meanwhile, Ozempic lawsuit cases continue to grow rapidly. MDL No. 3094 now has 3,636 gastrointestinal injury cases pending in the Eastern District of Pennsylvania. A separate vision loss MDL No. 3163 tracks 86 NAION claims. Judge Karen Marston scheduled a Science Day for June 2, 2026. The Tylenol autism MDL faces a critical appeal at the Second Circuit after Judge Cote granted summary judgment. The FDA has also begun adding pregnancy warnings to acetaminophen products.
Medical Device Lawsuit Developments
The hernia mesh lawsuit MDL is approaching a key milestone this summer. The Covidien bellwether trial in Patterson v. Covidien is scheduled for July 13, 2026. A second bellwether involving a Mississippi plaintiff will follow shortly after. Currently, 2,090 Covidien cases are pending. For example, these test trials will shape potential recovery amounts for thousands of claimants nationwide.
However, the broader medical device mass tort settlement news extends well beyond hernia mesh. The Paragard IUD MDL is expected to hold bellwether trials later in 2026. Courts are also advancing CPAP device litigation against Philips. Affected individuals should review how mass tort settlements work to understand the process ahead. Anyone experiencing complications from a medical device may qualify for a legal review with a licensed attorney.
Environmental Contamination Case Updates
Environmental mass tort settlement news saw major activity this week. On May 11, Minnesota’s MPCA filed a new lawsuit against 3M over ongoing PFAS pollution. Huntsville Utilities followed on May 14 with its own suit against 3M over drinking water contamination. The AFFF lawsuit MDL now contains over 15,232 pending cases. These “forever chemical” cases represent one of the largest environmental mass torts in American history.
Camp Lejeune settlement payments continue to progress slowly. The DOJ has paid more than $421 million through the Elective Option program since January 2025. However, fewer than 1% of the 400,000 filed claims have been resolved. Twenty-four cases are heading to trial in 2026. Elective Option payouts range from $100,000 to $550,000 depending on illness severity and exposure duration.
The Roundup lawsuit faces new scrutiny as mass tort settlement news develops around Bayer’s proposed $7.25 billion resolution. Critics note the deal allocates $675 million to attorney fees. Plaintiffs with cancer may receive only $10,000 to $165,000 each. Bayer still faces approximately 58,000 active Roundup claims. Researchers also found chemicals draining onto Myrtle Beach shorelines this week. Understanding tort reform by state can help affected residents know their rights.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Consumer Product Litigation News
Johnson & Johnson talcum powder litigation remains the largest consumer product mass tort in the nation. Over 67,376 claims are consolidated in MDL-2738. The Lancet recently retracted a key 1977 paper after discovering undisclosed J&J financial ties to its author. Court-appointed mediators oversaw settlement talks on April 27. However, J&J has not offered a global resolution. A Maryland jury awarded $1.5 billion to a single mesothelioma plaintiff in December 2025.
The hair relaxer lawsuit MDL grew to 11,526 cases as of May 2026. Discovery is now largely complete for the first wave of defendants. Judge Mary Rowland in the Northern District of Illinois plans to select bellwether cases soon. However, the first trial is not expected before mid-2027. For a broader understanding of these proceedings, read our guide on what is a mass tort.
In addition, rideshare safety litigation saw notable mass tort settlement news developments. Lyft sexual assault cases were consolidated while Uber faced an $8.5 million verdict. Adobe agreed to a $150 million settlement for consumer protection violations under ROSCA. These cases highlight the expanding scope of consumer product accountability in 2026.
Key Deadlines and What to Watch
Several critical dates are approaching in mass tort settlement news. The Ozempic NAION MDL Science Day is set for June 2, 2026. The Covidien hernia mesh bellwether trial begins July 13. Camp Lejeune trials are scheduled throughout the year. The Second Circuit will rule on the Tylenol autism MDL appeal soon. Bayer’s Roundup class settlement remains under intense judicial review.
For those tracking settlement news from week to week, the coming weeks may bring pivotal developments. Readers affected by any of these products or exposures should consult a licensed attorney promptly. Filing deadlines vary by state and case type. Use our eligibility quiz to see if you may qualify for legal review. Mass tort settlement news continues to evolve rapidly as courts push major MDLs toward resolution in 2026.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- North Carolina Tort Reform Guide
- New Jersey Tort Reform Guide
- Pennsylvania Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.